Category: Health Tips

Many patients have inquired about the need to use Ivermectin, Fenbendazole, and Mebendazole simultaneously. This will clarify the situation for you. Each of these substances operates through distinct mechanisms and targets cancer in unique ways.

Ivermectin vs. Fenbendazole vs. Mebendazole: 12 Powerful Anti-Cancer Mechanisms Each Uses to Attack Tumors

These repurposed medications were originally designed to fight parasites — but research and real-world use have shown they do much more. Each one attacks cancer on multiple biological fronts, helping shut down tumor growth, starve cancer cells, boost the immune system, and more.

Here’s a breakdown of how each works:

IVERMECTIN – 12 Known Anti-Cancer Actions
1. Inhibits WNT/ß-catenin pathway – stops cancer cell proliferation
2. Induces apoptosis – triggers programmed cancer cell death
3. Blocks importin a/ß transport proteins – prevents cancer cell replication
4. Inhibits PAK1 enzyme – reduces inflammation and tumor progression
5. Anti-angiogenic – stops formation of new blood vessels in tumors
6. Immune system modulator – enhances recognition of cancer cells
7. Autophagy disruptor – interferes with cancer cell survival strategies
8. Targets glioblastoma stem cells – effective in brain cancers
9. Inhibits mitochondrial respiration – cuts off energy supply to tumors
10. Disrupts mTOR signaling – slows cell growth
11. Overcomes chemotherapy resistance – makes chemo more effective
12. Antiviral properties – potentially helpful for virus-related cancers (like HPV)

FENBENDAZOLE – 12 Known Anti-Cancer Actions
1. Microtubule disruption – prevents cancer cells from dividing
2. Inhibits glucose uptake – starves cancer cells of energy
3. Activates p53 tumor suppressor gene – helps kill damaged cells
4. Triggers apoptosis (cell death) – particularly in lung, colon, and prostate cancer
5. Inhibits metastasis – prevents cancer from spreading
6. Enhances oxidative stress in cancer cells – makes them more vulnerable
7. Immune modulator – may help immune system target tumors
8. Blocks angiogenesis – stops tumors from building blood supply
9. Depletes glutathione in tumors – weakens their defense
10. Suppresses AKT signaling pathway – involved in cell survival
11. Restores normal cell cycle regulation – prevents uncontrolled growth
12. Synergistic with other natural agents (e.g., CBD, curcumin, vitamin D)

MEBENDAZOLE – 12 Known Anti-Cancer Action
1. Microtubule destabilization – similar to fenbendazole
2. Inhibits angiogenesis blocks new blood vessel growth
3. Triggers apoptosis – causes cancer cell death
4. Inhibits VEGF signaling – blocks tumor blood supply signals
5. Crosses blood-brain barrier – useful for brain cancers
6. Activates caspase-3/7 enzymes – involved in programmed cell death
7. Reduces MYC oncogene expression – slows tumor growth
8. Inhibits Bcl-2 protein – lowers cancer cell survival
9. Anti-metastatic – reduces spread of cancer
10. Disrupts mitochondrial function – energy production in tumor cells fails
11. Improves chemo sensitivity – helps standard treatments work better
12. Low toxicity + long safety record – used in humans for decades

Each of these medications targets cancer through different biological pathways. If you see this post and you have not been following me please do so to get daily updates on important information like this. The world needs to know about this.

In a double-blind crossover trial, twelve healthy men took a single dose of nattokinase. Within hours, their blood showed the unmistakable signature of clot breakdown.

Most people file nattokinase under “heart health” and move on. The research is more interesting than that.

In a double-blind crossover trial, twelve healthy men took a single dose of nattokinase. Within hours, measurable markers of fibrin breakdown appeared in their blood — D-dimer rose 44% by the six-hour mark, while fibrin degradation products climbed 21%.

Crucially, every value stayed within normal physiological range. Nattokinase wasn’t pushing the system into dangerous territory. It was shifting a healthy fibrinolytic system toward turnover rather than accumulation.

Why does this matter beyond cardiovascular health? Because circulation is how your body gets compounds to the liver and kidneys in the first place. Before anything can be processed and eliminated, it has to be transported there. A circulatory system that moves freely is a prerequisite for effective clearance — not an afterthought.

Full breakdown here: https://bit.ly/4vXYKQl

In 1968, researchers ran the largest randomised trial ever done on saturated fat.

Over 9,000 people in Minnesota state hospitals were split between animal fat and corn oil for years.

The corn oil group’s cholesterol dropped hard.

The full results never got published.

The raw data sat on magnetic tapes in a basement for over forty years.

A researcher named Christopher Ramsden tracked those tapes down in 2013 and ran the numbers the original team never released.

For every 30 point drop in cholesterol, death risk rose 22 percent.

The lower the cholesterol fell, the faster people died.

In the over 65s, each drop of roughly half a point on the cholesterol scale carried a 35 percent higher death risk within two years.

The trial is real.

It was double blind.

It was the gold standard design.

And it found the exact opposite of what dietary guidelines were about to be built on.

It sat unpublished for over forty years while the low fat, high vegetable oil advice became national policy.

This was not a small study lost in the noise.

It was the largest of its kind.

And the finding that mattered most never reached a single doctor’s desk for four decades.

That’s why I have all three in my pre-bed stack.

In a open-label pilot study published in *Clinical Therapeutics*, researchers investigated the effects of a dietary supplement containing the anti-inflammatory flavonoid luteolin in children with autism spectrum disorder (ASD). The 26-week study included children diagnosed with ASD who received a formulation containing luteolin (a flavonoid found in celery and chamomile), along with quercetin and rutin, designed to enhance absorption and provide antioxidant and anti-inflammatory effects. Because the study was open-label, all participants received the supplement and there was no placebo control group.

Behavioral changes were measured using standardized tools, including the Aberrant Behavior Checklist (ABC) and the Vineland Adaptive Behavior Scales (VABS). After 26 weeks, researchers reported reductions of approximately 26% to 35% in ABC subscales, including lethargy (social withdrawal), stereotypy (repetitive behaviors), hyperactivity, and inappropriate speech. Improvements were also observed in adaptive functioning domains such as communication and daily living skills. However, as a small pilot study without a control group, the findings are considered preliminary and require confirmation in larger randomized controlled trials.

PMID: 23688534